ALKERMES | Capitale Ordinario

Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2023-09
Acadia Pharmaceuticals USD 16K 0 2023-12
ALKERMES USD 1.72M 2K 2023-09
Amgen USD 32.75B 152M 2023-09
Eli Lilly USD 593.6M 0 2023-09
Gilead Sciences USD 1000K 0 2023-09
Intra Cellular Therapies USD 10K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
Otsuka Holdings JPY 81.69B 0 2023-09
Pfizer USD 478M 0 2023-09
Regeneron Pharmaceuticals USD 102K 0 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09



ALKERMES Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.